
doi: 10.1111/jsap.13333
pmid: 33900627
ObjectivesTo create awareness of single RHDV2 infections and cases of death despite immunisation with RHDV2‐specific vaccine.Materials and MethodsRetrospective case series of four companion rabbits. Patient signalment, vaccination history, pathology and molecular examinations were obtained from the medical records.ResultsThe animals died peracutely or with nonspecific symptoms like apathy and inappetence. Pathological examination indicated and molecular biological findings confirmed RHDV2 infection in four animals. Several partner animals died at the same time under the same circumstances.Clinical SignificanceThis is the first report of fatalities in RHDV2‐vaccinated companion rabbits due to rabbit haemorrhagic disease virus 2 infection with documented case and vaccination history. Veterinarians should be aware of possible single fatal RHDV2 infections despite vaccination, should initiate the clarification of suspected cases and inform vaccine manufacturers and competent authorities.
Hemorrhagic Disease Virus, Rabbit, Vaccination, Animals, Caliciviridae Infections, Retrospective Studies
Hemorrhagic Disease Virus, Rabbit, Vaccination, Animals, Caliciviridae Infections, Retrospective Studies
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 10 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
